| Revision as of 15:51, 18 December 2024 editIdoghor Melody (talk | contribs)Autopatrolled, Event coordinators, Extended confirmed users, Page movers, IP block exemptions, New page reviewers, Pending changes reviewers32,961 editsm clean upTag: AWB← Previous edit |
Revision as of 19:38, 18 December 2024 edit undoBoghog (talk | contribs)Autopatrolled, Extended confirmed users, IP block exemptions, New page reviewers, Pending changes reviewers, Rollbackers, Template editors137,699 edits ceTag: Disambiguation links addedNext edit → |
| Line 49: |
Line 49: |
|
| NIAID_ChemDB = |
|
| NIAID_ChemDB = |
|
| PDB_ligand = |
|
| PDB_ligand = |
|
| synonyms = Urocut |
|
| synonyms = Urocut, FK-176 |
|
|
|
|
|
<!--Chemical data--> |
|
<!--Chemical data--> |
| Line 58: |
Line 58: |
|
| StdInChIKey = BWNLUIXQIHPUGO-RDTXWAMCSA-N |
|
| StdInChIKey = BWNLUIXQIHPUGO-RDTXWAMCSA-N |
|
}} |
|
}} |
|
|
'''Vamicamide''', also known as FK-176 or Urocut, is a ] (mAChR) antagonist that was developed by ] (now part of ]) for the treatment of ] and ].<ref name = "PatSnap"/> This small molecule drug acts by blocking muscarinic receptors, which play a role in bladder function. Despite showing promise in preclinical studies for increasing bladder capacity without affecting other urinary parameters,<ref name="Yamamoto_1995">{{cite journal | vauthors = Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M | title = Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency | journal = The Journal of Urology | volume = 154 | issue = 6 | pages = 2174–8 | date = December 1995 | pmid = 7500484 | doi = | url = }}</ref> vamicamide has never been approved for medical use. The drug's development was ultimately discontinued, with its highest research and development status reaching the New Drug Application (NDA) or Biologics License Application (BLA) phase in Japan.<ref name = "PatSnap">{{cite web | title = Vamicamide | url = https://synapse.patsnap.com/drug/eaf5bdd08c71489181d6c8f1bc01a636 | work = PatSnap }}</ref> |
|
'''Vamicamide''' is an antimuscarinic drug.<ref>Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K. General pharmacology of the new antimuscarinic compound vamicamide. Arzneimittelforschung. 1995 Dec;45(12):1274-84. PMID 8595084. |
|
|
</ref> |
|
|
|
|
|
Vamicamide should be useful for the treatment of urinary frequency.<ref>Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M. Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. J Urol. 1995 Dec;154(6):2174-8. PMID 7500484.</ref> |
|
|
|
|
|
See also: ] (]). |
|
|
|
|
|
|
== References == |
|
== References == |
